Ideaya Biosciences Inc is a biotechnology company focused on the discovery and development of targeted therapeutics for the treatment of cancer

The company employs a precision medicine approach, leveraging its proprietary platform to identify and validate novel drug targets within various cancer types. By integrating advanced techniques in genomics and bioinformatics, Ideaya aims to create innovative therapies that specifically address the underlying genetic and molecular drivers of cancer, ultimately improving patient outcomes and extending survival. Its research pipeline includes a range of drug candidates currently in various stages of clinical development, demonstrating the company's commitment to advancing science and addressing unmet medical needs in oncology.